$TWST
Twist Bioscience Corp

2021 Q1 Form 10-Q Financial Statement

#000110465921063169 Filed on May 07, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1 2019 Q4
Revenue $31.20M $19.30M $17.16M
YoY Change 61.7% 42.34% 49.36%
Cost Of Revenue $19.03M $13.56M $13.79M
YoY Change 40.28% 15.06% 16.32%
Gross Profit $12.18M $5.733M $3.372M
YoY Change 112.38% 224.26% -1023.84%
Gross Profit Margin 39.02% 29.71% 19.65%
Selling, General & Admin $34.39M $27.19M $26.41M
YoY Change 26.48% 42.18% 73.05%
% of Gross Profit 282.43% 474.27% 783.07%
Research & Development $15.79M $10.63M $10.30M
YoY Change 48.57% 19.33% 41.58%
% of Gross Profit 129.69% 185.4% 305.37%
Depreciation & Amortization $2.470M $1.550M $1.505M
YoY Change 59.35% -1.27% 2.24%
% of Gross Profit 20.29% 27.04% 44.63%
Operating Expenses $50.18M $37.82M $36.70M
YoY Change 32.68% 34.92% 6.73%
Operating Profit -$38.00M -$32.09M -$55.83M
YoY Change 18.44% 22.17% 143.83%
Interest Expense $95.00K $215.0K $248.0K
YoY Change -55.81% -36.76% -28.74%
% of Operating Profit
Other Income/Expense, Net $84.00K $18.00K -$87.00K
YoY Change 366.67% -185.71% 480.0%
Pretax Income -$37.86M -$31.71M -$55.60M
YoY Change 19.4% 22.66% 146.07%
Income Tax $61.00K $61.00K $37.00K
% Of Pretax Income
Net Earnings -$37.92M -$31.77M -$55.64M
YoY Change 19.36% 22.5% 145.76%
Net Earnings / Revenue -121.52% -164.63% -324.16%
Basic Earnings Per Share -$0.78
Diluted Earnings Per Share -$0.78 -$855.0K -$1.687M
COMMON SHARES
Basic Shares Outstanding 48.71M shares 35.45M 33.12M
Diluted Shares Outstanding 48.71M shares

Balance Sheet

Concept 2021 Q1 2020 Q1 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $555.7M $230.1M $103.1M
YoY Change 141.5% 120.61% -20.81%
Cash & Equivalents $399.3M $184.4M $26.03M
Short-Term Investments $156.3M $45.70M $77.10M
Other Short-Term Assets $9.200M $4.600M $5.700M
YoY Change 100.0% 9.52% 42.5%
Inventory $15.84M $10.76M $7.416M
Prepaid Expenses
Receivables $27.29M $14.83M $13.05M
Other Receivables $3.100M $1.400M $1.000M
Total Short-Term Assets $608.0M $260.2M $129.3M
YoY Change 133.66% 115.06% -11.85%
LONG-TERM ASSETS
Property, Plant & Equipment $31.98M $23.27M $21.34M
YoY Change 37.43% 55.73% 56.95%
Goodwill $1.138M $1.138M $1.138M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.447M $2.424M $2.237M
YoY Change 42.2% 26.78% 23.18%
Total Long-Term Assets $69.29M $63.67M $62.99M
YoY Change 8.83% 231.96% 254.07%
TOTAL ASSETS
Total Short-Term Assets $608.0M $260.2M $129.3M
Total Long-Term Assets $69.29M $63.67M $62.99M
Total Assets $677.3M $323.9M $192.3M
YoY Change 109.12% 131.06% 16.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.528M $6.932M $9.106M
YoY Change 23.02% 53.87% 35.41%
Accrued Expenses $3.272M $3.491M $4.687M
YoY Change -6.27% 44.73% 79.85%
Deferred Revenue $600.0K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.168M $3.333M $3.333M
YoY Change -4.95% 0.0% 0.0%
Total Short-Term Liabilities $40.44M $30.21M $57.84M
YoY Change 33.87% 62.59% 204.47%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $2.925M $3.669M
YoY Change -100.0% -49.81% -43.78%
Other Long-Term Liabilities $422.0K $95.00K $144.0K
YoY Change 344.21% -66.31% -56.76%
Total Long-Term Liabilities $422.0K $3.020M $3.813M
YoY Change -86.03% -50.57% -44.41%
TOTAL LIABILITIES
Total Short-Term Liabilities $40.44M $30.21M $57.84M
Total Long-Term Liabilities $422.0K $3.020M $3.813M
Total Liabilities $63.11M $59.67M $89.20M
YoY Change 5.76% 141.68% 244.96%
SHAREHOLDERS EQUITY
Retained Earnings -$529.3M -$405.9M -$374.2M
YoY Change 30.39% 56.47% 60.24%
Common Stock $0.00 $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $614.2M $264.2M $103.1M
YoY Change
Total Liabilities & Shareholders Equity $677.3M $323.9M $192.3M
YoY Change 109.12% 131.06% 16.92%

Cashflow Statement

Concept 2021 Q1 2020 Q1 2019 Q4
OPERATING ACTIVITIES
Net Income -$37.92M -$31.77M -$55.64M
YoY Change 19.36% 22.5% 145.76%
Depreciation, Depletion And Amortization $2.470M $1.550M $1.505M
YoY Change 59.35% -1.27% 2.24%
Cash From Operating Activities -$24.55M -$58.68M -$34.91M
YoY Change -58.16% 181.84% 61.01%
INVESTING ACTIVITIES
Capital Expenditures -$8.400M -$2.740M $2.058M
YoY Change 206.57% -27.32% 7.08%
Acquisitions
YoY Change
Other Investing Activities $81.99M $31.50M $14.46M
YoY Change 160.29% -376.56% -122.65%
Cash From Investing Activities $73.59M $28.76M $12.41M
YoY Change 155.88% -289.71% -118.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $833.0K
YoY Change
Cash From Financing Activities 1.450M 188.0M 2.057M
YoY Change -99.23% -11635.58% -97.18%
NET CHANGE
Cash From Operating Activities -24.55M -58.68M -34.91M
Cash From Investing Activities 73.59M 28.76M 12.41M
Cash From Financing Activities 1.450M 188.0M 2.057M
Net Change In Cash 50.49M 158.1M -20.44M
YoY Change -68.07% -520.39% 41.55%
FREE CASH FLOW
Cash From Operating Activities -$24.55M -$58.68M -$34.91M
Capital Expenditures -$8.400M -$2.740M $2.058M
Free Cash Flow -$16.15M -$55.94M -$36.97M
YoY Change -71.13% 228.09% 56.62%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48860000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45083000
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001581280
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0
CY2020Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38720
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2823000
CY2021Q1 us-gaap Assets
Assets
677289000
CY2020Q3 us-gaap Assets
Assets
398882000
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
8528000
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4830000
dei Entity Registrant Name
EntityRegistrantName
Twist Bioscience Corporation
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-2058888
dei Entity Address Address Line1
EntityAddressAddressLine1
681 Gateway Blvd
dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
719-0671
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
TWST
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48894038
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
399329000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93667000
CY2021Q1 us-gaap Short Term Investments
ShortTermInvestments
156329000
CY2020Q3 us-gaap Short Term Investments
ShortTermInvestments
196335000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27290000
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26376000
CY2021Q1 us-gaap Inventory Net
InventoryNet
15838000
CY2020Q3 us-gaap Inventory Net
InventoryNet
12289000
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9213000
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6203000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
607999000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
334870000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31975000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25466000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
30997000
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
33699000
CY2021Q1 us-gaap Goodwill
Goodwill
1138000
CY2020Q3 us-gaap Goodwill
Goodwill
1138000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
203000
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
307000
CY2021Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1530000
CY2020Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
579000
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3447000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3272000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3901000
us-gaap Costs And Expenses
CostsAndExpenses
124377000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-458455000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
614181000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
336262000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
677289000
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14897000
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14945000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6514000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6409000
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
3168000
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3333000
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
4063000
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2611000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
40442000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
36029000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22244000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24837000
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1403000
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
422000
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
351000
CY2021Q1 us-gaap Liabilities
Liabilities
63108000
CY2020Q3 us-gaap Liabilities
Liabilities
62620000
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48860000
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45083000
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1143265000
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
794630000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
190000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
87000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-529274000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
398882000
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
31204000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
19297000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
59364000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
36461000
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
19028000
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
13564000
us-gaap Cost Of Revenue
CostOfRevenue
37190000
us-gaap Cost Of Revenue
CostOfRevenue
27356000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15791000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10629000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29791000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20926000
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
34389000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
27190000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
63181000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-38004000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-32086000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
53595000
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
22500000
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
69208000
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
51383000
us-gaap Costs And Expenses
CostsAndExpenses
130162000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
27000
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
38000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000
us-gaap Operating Income Loss
OperatingIncomeLoss
-70798000
us-gaap Operating Income Loss
OperatingIncomeLoss
-87916000
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
157000
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
576000
us-gaap Investment Income Interest
InvestmentIncomeInterest
291000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1140000
CY2021Q1 us-gaap Interest Expense
InterestExpense
95000
CY2020Q1 us-gaap Interest Expense
InterestExpense
215000
us-gaap Interest Expense
InterestExpense
213000
us-gaap Interest Expense
InterestExpense
463000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
84000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-69000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-37858000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-31707000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-70712000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-87308000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
61000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
61000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
107000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
98000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-37919000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-31768000
us-gaap Net Income Loss
NetIncomeLoss
-70819000
us-gaap Net Income Loss
NetIncomeLoss
-87406000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
10000
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
12000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
11000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
102000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37871000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31745000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-70716000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-87374000
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.78
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.85
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.50
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.49
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48709000
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37164000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47340000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35058000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
637952000
CY2021Q1 twst Prior Quarter Public Offering Expenses Adjustment
PriorQuarterPublicOfferingExpensesAdjustment
-36000
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3066000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2787000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
264202000
us-gaap Profit Loss
ProfitLoss
-70819000
CY2021Q1 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-3341000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11552000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
48000
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-37919000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
614181000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
103081000
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
186150000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1387000
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1522000
CY2020Q1 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-390000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4197000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
23000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-31768000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
264202000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
336262000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
323887000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9137000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2787000
us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-5751000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
18575000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
103000
us-gaap Profit Loss
ProfitLoss
-70819000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
614181000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
152082000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
188174000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3102000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1522000
us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-1198000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7894000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
32000
us-gaap Profit Loss
ProfitLoss
-87406000
us-gaap Profit Loss
ProfitLoss
-87406000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4575000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3064000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-2000
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
214000
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
-227000
us-gaap Share Based Compensation
ShareBasedCompensation
18575000
us-gaap Share Based Compensation
ShareBasedCompensation
7894000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-314000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
232000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
4000
us-gaap Other Noncash Expense
OtherNoncashExpense
44000
us-gaap Other Noncash Expense
OtherNoncashExpense
87000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
417000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
53000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
105000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1331000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2727000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3544000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3433000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2731000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1953000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
87000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
196000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3798000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3075000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-45000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3037000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-38000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-1848000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1126000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-601000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-49481000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-93585000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12030000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4795000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
58795000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
6537000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
98494000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
52500000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
27669000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
41168000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
9116000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
3061000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
323887000
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
188376000
twst Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
2787000
twst Proceeds From Issuance Of Common Stock Under Employee Stock Purchase Plan
ProceedsFromIssuanceOfCommonStockUnderEmployeeStockPurchasePlan
1522000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1667000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1667000
twst Payments To Repurchases Of Common Stock For Tax Withholding
PaymentsToRepurchasesOfCommonStockForTaxWithholding
5751000
twst Payments To Repurchases Of Common Stock For Tax Withholding
PaymentsToRepurchasesOfCommonStockForTaxWithholding
1198000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
328372000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
190094000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-18000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
306613000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
137659000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94246000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47398000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
400859000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
185057000
us-gaap Interest Paid Net
InterestPaidNet
109000
us-gaap Interest Paid Net
InterestPaidNet
271000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
120000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
197000
us-gaap Liabilities Assumed1
LiabilitiesAssumed1
774000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
63000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2833000
us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
203000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-529300000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
399329000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93667000
CY2021Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
1530000
CY2020Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
579000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
400859000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94246000
CY2021Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
800000
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
600000
CY2021Q1 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0
CY2020Q1 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
0
CY2021Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
555658000
CY2020Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
290002000
CY2021Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
24953000
CY2020Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
25790000
CY2021Q1 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
3068000
CY2020Q3 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
951000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
731000
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
365000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
27290000
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26376000
CY2021Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
11387000
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
9237000
CY2021Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2594000
CY2020Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2021000
CY2021Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1857000
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1031000
CY2021Q1 us-gaap Inventory Net
InventoryNet
15838000
CY2020Q3 us-gaap Inventory Net
InventoryNet
12289000
CY2020 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1240000
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1037000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
203000
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1240000
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
933000
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
307000
us-gaap Lessor Operating Lease Existence Of Option To Extend
LessorOperatingLeaseExistenceOfOptionToExtend
true
us-gaap Lessor Operating Lease Existence Of Option To Terminate
LessorOperatingLeaseExistenceOfOptionToTerminate
true
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
30997000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6514000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22244000
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
14.85
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3118000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
7169000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6766000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
6393000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
6433000
CY2021Q1 twst Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
4907000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
34786000
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6028000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
28758000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6514000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22244000
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
1900000
us-gaap Operating Lease Expense
OperatingLeaseExpense
3800000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1800000
us-gaap Operating Lease Payments
OperatingLeasePayments
3600000
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y1M6D
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07
CY2021Q1 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
1200000
CY2020Q1 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
900000
us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
2300000
us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
1600000
CY2020Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
26385
CY2020Q4 twst Stock Warrants Exercised
StockWarrantsExercised
18854
CY2020Q4 twst Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
6041
CY2020Q4 twst Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
16051
CY2020Q4 twst Stock Warrants Exercised
StockWarrantsExercised
7531
CY2020Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
21.24
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11552000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4197000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18575000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7894000
CY2021Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
33900000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y1M6D
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
30.33
CY2020Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
179000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
250000
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
49000
CY2021Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
380000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-37919000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-31768000
us-gaap Net Income Loss
NetIncomeLoss
-70819000
us-gaap Net Income Loss
NetIncomeLoss
-87406000
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
48709000
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37164000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
47340000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
35058000
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.78
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.85
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.50
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.49
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4271000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4706000
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
31204000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
19297000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
59364000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
36461000
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
31204000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
19297000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
59364000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
36461000
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
31204000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
19297000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
59364000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
36461000

Files In Submission

Name View Source Status
0001104659-21-063169-index-headers.html Edgar Link pending
0001104659-21-063169-index.html Edgar Link pending
0001104659-21-063169.txt Edgar Link pending
0001104659-21-063169-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
twst-20210331.xsd Edgar Link pending
twst-20210331x10q.htm Edgar Link pending
twst-20210331x10q004.jpg Edgar Link pending
twst-20210331x10q_htm.xml Edgar Link completed
twst-20210331xex31d1.htm Edgar Link pending
twst-20210331xex31d2.htm Edgar Link pending
twst-20210331xex32d1.htm Edgar Link pending
twst-20210331xex32d2.htm Edgar Link pending
twst-20210331_cal.xml Edgar Link unprocessable
twst-20210331_def.xml Edgar Link unprocessable
twst-20210331_lab.xml Edgar Link unprocessable
twst-20210331_pre.xml Edgar Link unprocessable